Stigma and Social Support in Pharmaceutical Opioid Treatment Populations: a Scoping Review
- 916 Downloads
Pharmaceutical opioid (PO) use and harms are increasing dramatically. Treatment related stigma may present as a treatment barrier for people who use PO. Additionally, differences in social support between PO and other opioid treatment populations may positively influence treatment outcomes. A scoping methodology was utilised to map current knowledge, with searches performed in Medline, PsycINFO and Embase. Eligibility criteria required articles related to stigma and social support in treatment for PO use. The search identified 44 relevant articles. Stigma themes included individual perceptions of opioid dependence, community perceptions of opioid dependence, blame as a stigmatising factor, language surrounding opioid use, and treatment experience. Social support themes included family as support, web-based support, friends as support, partners as support and social network therapy. Limited literature was found focussing specifically on stigma and social support in people who use PO, highlighting that this is an important area for future work.
KeywordsPharmaceutical opioids Stigma Social support Opioid substitution therapy Opioid dependence Opioid treatment
Compliance with Ethical Standards
Conflict of Interest
SN is supported by a National Health and Medical Research Council Research Fellowship (#1,013,803). The National Drug and Alcohol Research Centre at the University of New South Wales is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. SN has previously received untied education grants from Reckitt-Benckiser and Indivior. None of these funders had any role in this present work. Author SC has no conflicts to declare.
- Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269–1272. doi: 10.1176/appi.ps.201400140.CrossRefPubMedPubMedCentralGoogle Scholar
- Brown, S. E., & Altice, F. L. (2014). Self-management of buprenorphine/naloxone among online discussion board users. Subst. Use Misuse, 49(8), 1017–1024.Google Scholar
- Cooper, R. J. (2013). ‘I can’t be an addict. I am.’ Over-the-counter medicine abuse: a qualitative study. BMJ Open, 3(6). doi: 10.1136/bmjopen-2013-002913.
- Day, E., Copello, A., Karia, M., Roche, J., Grewal, P., George, S., et al. (2013). Social network support for individuals receiving opiate substitution treatment and its association with treatment progress. European Addiction Research, 19(4), 211–221. doi: 10.1159/000343827.CrossRefPubMedGoogle Scholar
- Earnshaw, V., Smith, L., & Copenhaver, M. (2013). Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. International Journal of Mental Health and Addiction, 11(1), 110–122. doi: 10.1007/s11469-012-9402-5.CrossRefPubMedGoogle Scholar
- Fischer, B., Jones, W., & Rehm, J. (2013). High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiology and Drug Safety, 22(4), 438–442. doi: 10.1002/pds.3404.CrossRefPubMedGoogle Scholar
- Kelly, S. M., O’Grady, K. E., Schwartz, R. P., Peterson, J. A., Wilson, M. E., & Brown, B. S. (2010). The relationship of social support to treatment entry and engagement: the community assessment inventory. Substance Abuse, 31(1), 43–52. doi: 10.1080/08897070903442640.CrossRefPubMedPubMedCentralGoogle Scholar
- Levac, D., Colquhoun, H., & O’Brien, K. K. (2010). Scoping studies: advancing the methodology. Implementation Science, 5(69). doi: 10.1186/1748-5908-5-69.
- Maarefvand, M., Eghlima, M., Rafiey, H., Rahgozar, M., Tadayyon, N., Deilamizadeh, A., & Ekhtiari, H. (2015). Community-based relapse prevention for opiate dependents: a randomized community controlled trial. Community Mental Health Journal, 51(1), 21–29. doi: 10.1007/s10597-014-9772-1.CrossRefPubMedGoogle Scholar
- Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane database of systematic reviews, CD002207.Google Scholar
- McMurphy, S., Shea, J., Switzer, J., & Turner, B., J. (2006). Clinic-based treatment for opioid dependence: a qualitative inquiry. American Journal of Health Behavior, 544(54).Google Scholar
- Nielsen, S., Cameron, J., & Pahoki, S. (2010). Over the counter codeine dependence. Retrieved from Melbourne:Google Scholar
- Nielsen, S., Bruno, R., Lintzeris, N., Fischer, J., Carruthers, S., & Stoove, M. (2011). Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia? Drug and Alcohol Review, 30(3), 291–299. doi: 10.1111/j.1465-3362.2011.00302.x.CrossRefPubMedGoogle Scholar
- Nielsen, S., Hillhouse, M., Mooney, L., Ang, A., & Ling, W. (2015a). Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users. Journal of Substance Abuse Treatment, 48(1), 70–76. doi: 10.1016/j.jsat.2014.06.006.CrossRefPubMedGoogle Scholar
- Nielsen, S., Roxburgh, A., Bruno, R., Lintzeris, N., Jefferson, A., & Degenhardt, L. (2015b). Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. Drug and Alcohol Dependence, 149, 212–219. doi: 10.1016/j.drugalcdep.2015.02.004.CrossRefPubMedGoogle Scholar
- Nielsen, S., Larance, B., Degenhardt, L., Gowing, L., Kehler, C., & Lintzeris, N. (2016). Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane database of systematic reviews, In Press(Accepted 220416).Google Scholar
- Orizio, G., Schulz, P., Gasparotti, C., Caimi, L., & Gelatti, U. (2010). The world of e-patients: a content analysis of online social networks focusing on diseases. Telemed J E Health, 16(10):1060–6. doi: 10.1089/tmj.2010.0085.
- Roxburgh, A. a. B., L. (2015). Accidental drug-induced deaths due to opioids in Australia, 2011. Retrieved from Sydney:Google Scholar
- Scimeca, M., Savage, S., Portenoy, R., & Lowinson, J. (2000). Treatment of pain in methadone-maintained patients. Mount Sinai Journal of Medicine, 67(5–7).Google Scholar
- Substance Abuse and Mental Health Services Administration (2010). Substance abuse treatment admissions involving abuse of pain relievers: 1998 and 2008. Substance Abuse and Mental Health Services Administration (SAMHSA): Office of Applied Studies.Google Scholar
- Tomori, C., Go, V. F., Tuan le, N., Huong, N. M., Binh, N. T., Zelaya, C. E., et al. (2014). "in their perception we are addicts": social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam. International Journal of Drug Policy, 25(5), 897–904. doi: 10.1016/j.drugpo.2014.04.012.CrossRefPubMedPubMedCentralGoogle Scholar